Skip to main content
. 2009 May 13;14(8):2122–2131. doi: 10.1111/j.1582-4934.2009.00788.x

Table 3.

Test characteristics of cycle sequencing and real-time PCR-based assay for KRAS mutation assessment (n 5 510)

Cycle sequencing Real-time PCR-based assay
Sensitivity 95.5% 96.5%
(95% CI) (91.7–97.9%) (93.0–98.6%)
Specificity 99.7% 98.1%
(95% CI) (98.2–100%) (95.8–99.3%)
Positive predictive value 99.5% 97.0%
(95% CI) (97.1–100%) (93.6–98.9%)
Negative predictive value 97.2% 97.7%
(95% CI) (94.7–98.7%) (95.4–99.1%)